New fast-acting anti-depressant drug administered as nasal spray is first released in decades, offers new hope for depressive disorder treatment Depression and anxiety often afflict people simultaneously, and there is new hope to the 16.1 million adults suffering from treatment-resistant Major Depressive Disorder. The new drug, Spravato®, offers hope to those that have treatment-resistant depression … Continue reading Close Relative of Club Drug Offers New Hope for Depression Treatment